semaglutide in atlanta GLP-1 Atlanta, GA Semaglutide in Atlanta: What You

7881 GLP-1RAs, initially developed for diabetes, have recently shown potential in stroke treatment

For example, Wegovy is licensed specifically to reduce cardiovascular risk in people with raised BMI something that becomes increasingly relevant during menopause

Retatrutide's addition of glucagon receptor activation to this dual agonist foundation appears to provide the incremental benefit needed to push efficacy into previously uncharted territory

These medications also show promising effects on the immune system by decreasing high-sensitivity C-reactive protein (hs-CRP) a key marker of inflammation and cardiovascular risk

Declaration of interest C R A and A A declare no conflicts of interest